Get 40% Off
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list

COVID-19 vaccine access, not acceptance, key issue in Americas -PAHO

Published 06/16/2021, 01:44 PM
Updated 06/16/2021, 01:47 PM
© Reuters. FILE PHOTO: People wait to receive an AstraZeneca coronavirus disease (COVID-19) vaccine during a vaccination campaign for homeless people, in Rio de Janeiro's downtown, Brazil, May 27, 2021. REUTERS/Ricardo Moraes/File Photo

By Julia Symmes Cobb

BOGOTA (Reuters) -The primary issue with lagging COVID-19 vaccinations in the Americas is access to doses, not acceptance of vaccine safety or efficacy, the Pan American Health Organization (PAHO) said on Wednesday, urging donor countries to send shots as soon as possible.

The Group of Seven rich nations said on Sunday they will provide 1 billion vaccine doses over the next year to help poorer countries inoculate their populations.

"I want to be clear that the primary issue in the Americas is vaccine access, not vaccine acceptance," PAHO Director Carissa Etienne said during the organization's weekly news conference. "We're counting on our leaders and the support of the global community to ensure the Americas have the doses they need – as soon as possible – to save lives."

The G7 pledge offers fresh hope the region will overcome supply barriers, she said. But even with the donation the Americas remains a long way from protecting its population.

"We hope G7 nations will prioritize doses for countries at greatest risk – especially those in Latin America that have not yet had access to enough vaccines to even protect even the most vulnerable," she said. "Vaccines are urgently needed today."

Over 1.1 million new cases of COVID-19 and 31,000 deaths were reported in the Americas last week, Etienne said, with particular upticks in six Mexican states, Belize, Guatemala, Panama and some places in the Caribbean.

Hospitals in Bolivia, Chile and Uruguay are largely seeing COVID-19 patients between the ages of 25 and 40 as the trend toward younger patients continued. In Brazil's Sao Paulo, 80% of intensive care units (ICU) occupants are COVID-19 patients.

Colombia's COVID-19 situation is at its highest point nationally, with ICU beds largely filled in major cities, Etienne added, urging countries to tighten public health measures in places with high transmission.

Haiti, which has not yet begun vaccinations, will be prioritized for doses from the COVAX vaccine distribution program expected to arrive in July, PAHO subdirector Jarbas Barbosa said.

Countries must provide clear information about when people can get shots and make sure they get their second doses, Etienne said. People skipping their second dose does not seem to be a widespread phenomenon, she added.

© Reuters. FILE PHOTO: People wait to receive an AstraZeneca coronavirus disease (COVID-19) vaccine during a vaccination campaign for homeless people, in Rio de Janeiro's downtown, Brazil, May 27, 2021. REUTERS/Ricardo Moraes/File Photo

No country will be safe until high vaccination coverage is reached, Sylvain Aldighieri, PAHO's COVID-19 incident manager added.

"No country and definitely no region of the world is protected from new peaks of transmission."

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.